These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7913128)

  • 1. Interactions between classic psychedelics and serotonergic antidepressants: Effects on the acute psychedelic subjective experience, well-being and depressive symptoms from a prospective survey study.
    Barbut Siva J; Barba T; Kettner H; Kuc J; Nutt DJ; Carhart-Harris R; Erritzoe D
    J Psychopharmacol; 2024 Feb; 38(2):145-155. PubMed ID: 38281075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Psychedelic Assisted Therapy" Must Not Be Retired.
    Deckel GM; Lepow LA; Guss J
    Am J Psychiatry; 2024 Jan; 181(1):77-78. PubMed ID: 38161309
    [No Abstract]   [Full Text] [Related]  

  • 3. The Intricate Interaction Between Expectations and Therapeutic Outcomes of Psychedelic Agents.
    Colloca L; Nikayin S; Sanacora G
    JAMA Psychiatry; 2023 Sep; 80(9):867-868. PubMed ID: 37405764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of alcoholism using psychedelic drugs: a review of the program of research.
    Mangini M
    J Psychoactive Drugs; 1998; 30(4):381-418. PubMed ID: 9924844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aromatic Bromination Abolishes the Psychomotor Features and Pro-social Responses of MDMA ("Ecstasy") in Rats and Preserves Affinity for the Serotonin Transporter (SERT).
    Sáez-Briones P; Castro-Castillo V; Díaz-Véliz G; Valladares L; Barra R; Hernández A; Cassels BK
    Front Pharmacol; 2019; 10():157. PubMed ID: 30873030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine.
    Dunlap LE; Andrews AM; Olson DE
    ACS Chem Neurosci; 2018 Oct; 9(10):2408-2427. PubMed ID: 30001118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (±)-MDMA and its enantiomers: potential therapeutic advantages of R(-)-MDMA.
    Pitts EG; Curry DW; Hampshire KN; Young MB; Howell LL
    Psychopharmacology (Berl); 2018 Feb; 235(2):377-392. PubMed ID: 29248945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The serotonin 5-HT
    Canal CE; Murnane KS
    J Psychopharmacol; 2017 Jan; 31(1):127-143. PubMed ID: 27903793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years.
    Dos Santos RG; Osório FL; Crippa JA; Riba J; Zuardi AW; Hallak JE
    Ther Adv Psychopharmacol; 2016 Jun; 6(3):193-213. PubMed ID: 27354908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressive and anxiolytic effects of ayahuasca: a systematic literature review of animal and human studies.
    Dos Santos RG; Osório FL; Crippa JA; Hallak JE
    Braz J Psychiatry; 2016 Mar; 38(1):65-72. PubMed ID: 27111702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3,4-methylenedioxymethamphetamine (MDMA): current perspectives.
    Meyer JS
    Subst Abuse Rehabil; 2013; 4():83-99. PubMed ID: 24648791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MDMA (3,4-Methylenedioxymethamphetamine) Analogues as Tools to Characterize MDMA-Like Effects: An Approach to Understand Entactogen Pharmacology.
    Sáez-Briones P; Hernández A
    Curr Neuropharmacol; 2013 Sep; 11(5):521-34. PubMed ID: 24403876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of persistent effects of ketamine in rodent models of depression.
    Popik P; Kos T; Sowa-Kućma M; Nowak G
    Psychopharmacology (Berl); 2008 Jun; 198(3):421-30. PubMed ID: 18458881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The psychotherapeutic potential of MDMA (3,4-methylenedioxymethamphetamine): an evidence-based review.
    Parrott AC
    Psychopharmacology (Berl); 2007 Apr; 191(2):181-93. PubMed ID: 17297639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of transpersonal theory and its application to the practice of psychotherapy.
    Kasprow MC; Scotton BW
    J Psychother Pract Res; 1999; 8(1):12-23. PubMed ID: 9888104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychedelic and entactogenic drugs in the treatment of depression.
    Riedlinger TJ; Riedlinger JE
    J Psychoactive Drugs; 1994; 26(1):41-55. PubMed ID: 7913128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can drugs be used to enhance the psychotherapeutic process?
    Grinspoon L; Bakalar JB
    Am J Psychother; 1986 Jul; 40(3):393-404. PubMed ID: 2876654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in the stimulus properties of 3,4-methylenedioxyamphetamine and 3,4- methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline.
    Callahan PM; Appel JB
    J Pharmacol Exp Ther; 1988 Sep; 246(3):866-70. PubMed ID: 2901488
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.